Search research articles
Contact Us
Filters
Showing results (161-170 of 177) with videos related to
Page
of 18
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association
|
May 20, 2026
Prognostic Significance of Pretreatment Blood-Based Biomarkers in Penile Cancer: A Multicenter Retrospective Study in Japan
Shuichi Tatarano, Makito Miyake, Yu Osaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
January 26, 2022
Efficacy of combined androgen blockade therapy in patients with metastatic hormone-sensitive prostate cancer stratified by tumor burden
Yoshiyuki Nagumo, Mizuki Onozawa, Takahiro Kojima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
February 15, 2023
Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non-muscle invasive bladder cancer: A multi-institutional collaborative study
Tatsuki Miyamoto, Makito Miyake, Tomonori Nakahama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
December 26, 2023
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401
Akira Yokomizo, Masaki Shiota, Futoshi Morokuma, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
December 19, 2023
Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma 2023 by the Japanese Urological Association
Kazuyuki Mori, Shingo Hatakeyama, Hideki Enokida, et al.
European Urology Open Science
|
July 11, 2022
Site-specific Risk Stratification Models for Postoperative Recurrence and Survival Prediction in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: Better Stratification for Adjuvant Therapy
Makito Miyake, Kota Iida, Nobutaka Nishimura, et al.
Cancers
|
February 10, 2024
Enzalutamide versus Abiraterone Plus Prednisolone for Nonmetastatic Castration-Resistant Prostate Cancer: A Sub-Analysis from the ENABLE Study for PCa
Koji Mita, Kouji Izumi, Akihiro Goriki, et al.
Plos One
|
February 26, 2016
Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction
Siew-Kee Low, Koya Fukunaga, Atsushi Takahashi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
July 17, 2014
Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men
Inik Chang, Shinichiro Fukuhara, Darryn K Wong, et al.
Japanese Journal of Clinical Oncology
|
June 7, 2023
Real-world treatment outcomes of patients with penile cancer in the Kyushu-Okinawa area of Japan in the pre-guideline era
Takahiro Yamaguchi, Masato Goya, Katsuyoshi Higashijima, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 177) with videos related to
Sort By:
Page
of 18
International Journal of Urology : Official Journal of the Japanese Urological Association
|
May 20, 2026
Prognostic Significance of Pretreatment Blood-Based Biomarkers in Penile Cancer: A Multicenter Retrospective Study in Japan
Shuichi Tatarano, Makito Miyake, Yu Osaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
January 26, 2022
Efficacy of combined androgen blockade therapy in patients with metastatic hormone-sensitive prostate cancer stratified by tumor burden
Yoshiyuki Nagumo, Mizuki Onozawa, Takahiro Kojima, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
February 15, 2023
Validation of the risk stratification newly defined in the Japanese Urological Association guidelines 2019 for non-muscle invasive bladder cancer: A multi-institutional collaborative study
Tatsuki Miyamoto, Makito Miyake, Tomonori Nakahama, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
December 26, 2023
GnRH antagonist monotherapy versus a GnRH agonist plus bicalutamide for advanced hormone-sensitive prostate cancer; KYUCOG-1401
Akira Yokomizo, Masaki Shiota, Futoshi Morokuma, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
December 19, 2023
Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma 2023 by the Japanese Urological Association
Kazuyuki Mori, Shingo Hatakeyama, Hideki Enokida, et al.
European Urology Open Science
|
July 11, 2022
Site-specific Risk Stratification Models for Postoperative Recurrence and Survival Prediction in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy: Better Stratification for Adjuvant Therapy
Makito Miyake, Kota Iida, Nobutaka Nishimura, et al.
Cancers
|
February 10, 2024
Enzalutamide versus Abiraterone Plus Prednisolone for Nonmetastatic Castration-Resistant Prostate Cancer: A Sub-Analysis from the ENABLE Study for PCa
Koji Mita, Kouji Izumi, Akihiro Goriki, et al.
Plos One
|
February 26, 2016
Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction
Siew-Kee Low, Koya Fukunaga, Atsushi Takahashi, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
July 17, 2014
Cytochrome P450 1B1 polymorphisms and risk of renal cell carcinoma in men
Inik Chang, Shinichiro Fukuhara, Darryn K Wong, et al.
Japanese Journal of Clinical Oncology
|
June 7, 2023
Real-world treatment outcomes of patients with penile cancer in the Kyushu-Okinawa area of Japan in the pre-guideline era
Takahiro Yamaguchi, Masato Goya, Katsuyoshi Higashijima, et al.
Page
of 18